MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.35
52-Week Change 3-58.72%
S&P500 52-Week Change 38.36%
52 Week High 31.1500
52 Week Low 30.2000
50-Day Moving Average 30.5179
200-Day Moving Average 30.5036

Share Statistics

Avg Vol (3 month) 32.76k
Avg Vol (10 day) 33.6k
Shares Outstanding 515.31M
Float 4.23M
% Held by Insiders 118.10%
% Held by Institutions 150.60%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2850/1
Last Split Date 3Nov 26, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin -7.41%
Operating Margin (ttm)-2.32%

Management Effectiveness

Return on Assets (ttm)-5.28%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)106.6M
Revenue Per Share (ttm)7.30
Quarterly Revenue Growth (yoy)12.30%
Gross Profit (ttm)32.15M
Net Income Avi to Common (ttm)-7.9M
Diluted EPS (ttm)-0.5410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.75M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)19.49M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.93
Book Value Per Share (mrq)-1.14

Cash Flow Statement

Operating Cash Flow (ttm)-771k
Levered Free Cash Flow (ttm)2.86M